Open Mic: Next in Health series

Decoding immunity: Designing the next generation of precision therapies

30 Nov 2026

16:30 - 17:45

English

Online

Novartis Pavillon, St. Johanns-Hafen-Weg, 5, 4056 Basel

Unfortunately, we are already fully booked on site, but we are happy to welcome you online upon registration. If after your online registration you’d like to be included on the waiting list for the on site participation please contact us via events@baselarea.swiss. We will send you a confirmation if a seat becomes available.
The immune system is one of the most powerful – and complex – systems in human biology. What if we could not only understand it better, but predict how it will respond and ultimately learn how to shape it?

Advances in immune profiling, functional biology, AI and immune engineering are opening new possibilities to move from observing the immune system to understanding and influencing its behavior. By making immune responses more measurable and predictable, these approaches could help uncover new therapeutic targets, identify which patients are most likely to benefit from a treatment, reduce uncertainty in drug development, and enable a new generation of precision therapies.

This Open Mic will explore the rapidly evolving frontier of precision immunology: how we can decode, predict and ultimately design immune responses, and what this shift could mean for the discovery and development of tomorrow’s medicines.

Join us for a dynamic discussion on mapping human immunity and engineering new therapeutic approaches, bringing together perspectives from science, technology and drug development to address the question: How close are we to making the immune system truly predictable – and programmable?

Participation is free; however, registration is required by November 23.      

Agenda

16:00

Door opening

16:30

Welcome

16:30

Panel discussion

  • Mireia Gomez, Moderator, Biopharma Advisor
  • Sai Reddy, Scientific Director, Botnar Institute of Immune Engineering & Professor, ETH Zurich
  • Darragh Duffy, Co-founder & CSO, Kairo Bio & Research Director, Institut Pasteur
  • Richard Siegel, Global Head, Immunology, Biomedical Research, Novartis
17:45

Networking apéro

Share this event: